Hepatitis A
Material: | Serology: 1 ml serum PCR: Bean-sized fresh stool sample (external service) |
Methods: |
Ligandenassays → Chemilumineszenz-Immunoassay (CLIA) Amplifikationsverfahren → Real-time-PCR | Reference range | IgG: negative |
Indication | Suspicion of hepatitis A infection, hepatitis A immunization status | Mandatory reporting | ja Direct and indirect demonstration is reported to the health department by the laboratory by stating the patient’s name. Suspicion of an acute hepatitis A as well as illness and death have to be reported by the treating physician. |
Please note | In Germany, hepatitis A is mainly seen as a travel-infection (Endemic areas: the Mediterranean, the Orient, Tropics and Subtropics). Mode of transmission is fecal-orally. Around 4 weeks after infection, quite often there is icterus with transaminase increase. Chronic courses of illness are not known; in case of pre-existent hepatitis B or C infection there may be fulminant courses with high lethality (rare). In case of an infection during pregnancy, a transplacental transmission is largely impossible. In approximately 15 % of cases, there is a prolonged and often cholestatic course of illness. At the start of a fresh hepatitis A, both IgG- and IgM antibodies can be seen at the same time. Prior to a planned vaccination, testing of anti-HAV-IgG is useful in younger patients. Following vaccination, a 10 – 15 year immunization protection can be assumed. Currently there is no experience as to the protection period in dependence on anti-HAV-IgG concentration. A virus demonstration in stool confirms a fresh hepatitis A and correlates with the infectiosity. |
External services | ja MVZ Prof. Dr. med. Gisela Enders & Kollegen Stuttgart |
Accredited | ja |
More Results for the letter H
- HIV (Human immune deficiency virus) (HIV, HIVBL)
- HIV-antibodies, HIV-1-/HIV-2 screening test, HIV-1-/HIV-2 immunoblot
- HIV resistance assessment (HIVRES)
- HLA B27 (HLAB)
- PCR
- HLA DR, DQ (HLAD)
- HLA typing (HLA)
- Human leucocyte antigen, HLA-A, -B, -C, -DR, full typing
- HLA-B-27 (HLA27P)
- HLA-B-5701 (HLAB57)
- Holotranscobalamin (HOLO)
- HOMA-IR (evaluation of insulin resistance) (HOMA)
- Homocysteine, total (HOMOC)
- Homocystine (HOMOCU)
- Homogentisic acid (HOMOG)
- Homovanillic acid (HVS)
- Homovanillinic acid (HOMO04)
- HVA
- Hookworm (ANDUO, NECA)
- European hookworm, ancylostoma duodenale, necator americanus
- Howell-Jolly bodies (HOJO)
- HTLV-I/II (HTLV, HTLVQ)
- Human T-lymphotropic viruses, human T-cell leukemia viruses
- Human metapneumovirus (HMPV)
- Hydroxybutyrate (HYDR01)
- b-Hydroxybutyrate
- Hydroxycorticosteroids (-17) in urine (HYDRO17)
- Hydroxylase deficiency (CYP11B1), genetic analysis (11β-) (HYDR03(11b))
- Hydroxylase deficiency (CYP21), genetic analysis (21-) (HYDR02(21))
- Hydroxyprogesterone (17α-) (HYDR04(17α))
- Hydroxyproline, total in urine (HYPRU1)
- Hydroxypyren (1-) (HYDR06(1))
- metabolite of polycyclic aromatic hydrocarbons
- Hygiene examinations in hospital (HYG)
- Hymenolepis nana (HYMENO)
- Dwarf tapeworm